Answers are grounded in this paper and cite their sources.
The estimated costs are modest for measuring the benefits of new therapeutic agents but rise exponentially as more patients and clinic visits are required to establish a drug effect.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: